Geneva, Switzerland (HRNW) – The World Health Organization (WHO) has issued updated emergency guidance on the use of the licensed Ervebo Ebola vaccine during outbreaks caused by the Bundibugyo virus. The move comes as health authorities continue responding to the serious outbreak in the Democratic Republic of the Congo. WHO is also holding a technical webinar today focused on improving survival and clinical management of filovirus diseases, including Ebola and Marburg.
Support HRNW
Support independent health and human-rights journalism by contributing to HRNW:
Disclaimer
Disclaimer: This report is based on official WHO information and other reputable sources. HRNW is an independent news platform and is not affiliated with or endorsed by WHO or the United Nations.
